Roivant is a global biopharmaceutical company headquartered in New York and Basel, Switzerland, dedicated to rapidly delivering innovative medicines and technologies to patients.

We achieve this by building agile, focused companies – called Vants – that leverage technology and a unique approach to talent acquisition and incentive alignment. Roivant’s mission is to improve health by addressing unmet medical needs across a range of therapeutic areas, including autoimmune diseases, pulmonary diseases, and rare pediatric conditions.

Our streamlined operational model and commitment to rigorous capital allocation enable us to accelerate the development and commercialization of transformative medicines, ultimately benefiting patients worldwide. We are focused on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs.

Immunovant | Roivant

Service description

Roivant New York, United States (US)

Price: N/A

Roivant
New York, United States (US)